Low-Residue Diet Before Laparoscopic Surgery for Endometrial Cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized trial compares a standardized 3-day low-residue bowel-preparation diet to a traditional rectal enema before elective laparoscopic surgery for endometrial cancer. It aims to see if the diet provides surgical exposure comparable to the enema while potentially reducing physiological burden and patient discomfort. Intraoperative measures include the minimum Trendelenburg position and minimum pneumoperitoneum pressure needed for adequate visualization, along with other operative outcomes. Eligible participants are adults with endometrial cancer scheduled for laparoscopic surgery, randomized to one of the two preoperative preparations. The study addresses whether dietary bowel preparation can maintain adequate conditions without the use of an enema and whether one method offers tolerability advantages.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female participants aged 18 to 90 years.
* Scheduled to undergo elective laparoscopic surgery for endometrial cancer.
* Willing and able to provide written informed consent.

Exclusion Criteria:

* Planned open (abdominal) surgery.
* Known allergy or contraindication to sodium phosphate rectal enema.
* Age over 90 years.
* Refusal or inability to provide written informed consent.

Where it's running

• Başakşehir Çam and Sakura City Hospital
  Istanbul, Turkey (Türkiye) Recruiting

Study contacts

• Principal investigator: Mahmut Yassa, MD — Başakşehir Çam & Sakura City Hospital
• Study coordinator: Mahmut Yassa, MD
• Email: mahmut_yassa@hotmail.com
• Phone: +90 539 663 54 84

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized navigation to support rural and Black women with endometrial cancer

  This pilot tests a tailored patient-navigation program to help rural and Black patients with endometrial cancer access care and services.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07927244

• CR-002 study in adults with advanced solid tumors

  This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors

  Recruiting at 3 sites Phase 1/2 Crescent Biopharma, Inc. · Austin, Texas and 2 other locations · NCT07909031

• Methylation markers in self-samples to help detect gynecological cancers

  This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.

  Recruiting Universiteit Antwerpen · Edegem, Antwerp · NCT07902375

• One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy

  This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07895212

• Liquid biopsy screening for early endometrial cancer in regional China

  A non-invasive blood test using cell-free DNA is being tested to see if it can detect early endometrial cancer and tell apart benign from malignant uterine lesions.

  Recruiting Guizhou Provincial People's Hospital · Guiyang, Guizhou · NCT07892755

• Radiotherapy for gynecologic cancer with up to 10 metastatic sites

  This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość · NCT07883798

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.